Rifaximin

Rifaximin Struktur
80621-81-4
CAS-Nr.
80621-81-4
Englisch Name:
Rifaximin
Synonyma:
XIFAXAN;RIFAMIXIN;l105;normix;l105sv;Riimim;RIFACOL;Rifaxin;Ritacol;RIFAXIMIN
CBNumber:
CB5244184
Summenformel:
C43H51N3O11
Molgewicht:
785.89
MOL-Datei:
80621-81-4.mol

Rifaximin Eigenschaften

Schmelzpunkt:
200-2050C (dec)
Dichte
1.36±0.1 g/cm3(Predicted)
storage temp. 
Sealed in dry,Store in freezer, under -20°C
Löslichkeit
ethanol: soluble1mg/mL
pka
2.83±0.70(Predicted)
Aggregatzustand
powder
Farbe
dark orange
Merck 
14,8220
Stabilität:
Hygroscopic
InChIKey
NZCRJKRKKOLAOJ-XRCRFVBUSA-N
Sicherheit
  • Risiko- und Sicherheitserklärung
  • Gefahreninformationscode (GHS)
WGK Germany  2
RTECS-Nr. KD1576000
HS Code  2941.90.3000
Toxizität LD50 orally in rats: >2000 mg/kg (Borelli, Bertoli)
Bildanzeige (GHS) GHS hazard pictograms
Alarmwort Warnung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H312 Gesundheitsschädlich bei Hautkontakt. Akute Toxizität dermal Kategorie 4 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P280,P302+P352, P312, P322, P363,P501
H332 Gesundheitsschädlich bei Einatmen. Akute Toxizität inhalativ Kategorie 4 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P261, P271, P304+P340, P312
H335 Kann die Atemwege reizen. Spezifische Zielorgan-Toxizität (einmalige Exposition) Kategorie 3 (Atemwegsreizung) Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" />
H361 Kann vermutlich die Fruchtbarkeit beeinträchtigen oder das Kind im Mutterleib schädigen. Reproduktionstoxizität Kategorie 2 Warnung P201, P202, P281, P308+P313, P405,P501
Sicherheit
P201 Vor Gebrauch besondere Anweisungen einholen.
P202 Vor Gebrauch alle Sicherheitshinweise lesen und verstehen.
P261 Einatmen von Staub vermeiden.
P271 Nur im Freien oder in gut belüfteten Räumen verwenden.
P280 Schutzhandschuhe/Schutzkleidung/Augenschutz tragen.
P281 Vorgeschriebene persönliche Schutzausrüstung verwenden.
P302+P352 BEI BERÜHRUNG MIT DER HAUT: Mit viel Wasser/... (Hersteller kann, falls zweckmäßig, ein Reinigungsmittel angeben oder, wenn Wasser eindeutig ungeeignet ist, ein alternatives Mittel empfehlen) waschen.
P304+P340 BEI EINATMEN: Die Person an die frische Luft bringen und für ungehinderte Atmung sorgen.
P308+P313 BEI Exposition oder falls betroffen: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.
P312 Bei Unwohlsein GIFTINFORMATIONSZENTRUM/Arzt/... (geeignete Stelle für medizinische Notfallversorgung vom Hersteller/Lieferanten anzugeben) anrufen.
P322 Gezielte Maßnahmen
P363 Kontaminierte Kleidung vor erneutem Tragen waschen.
P405 Unter Verschluss aufbewahren.
P501 Inhalt/Behälter ... (Entsorgungsvorschriften vom Hersteller anzugeben) zuführen.

Rifaximin Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Rifaximin is an antibiotic structurally related to rifamycin. It is reported to be efficacious in the treatment of gastrointestinal infections and hepatic encephalopathy, being highly active against Gram-positive and -negative aerobic and anaerobic bacteria. Due to poor systemic absorption, rifaximin is effective in presurgical sterilization of the GI tract.It displays good activity against a wide spectrum of bacteria, including Salmonella spp., S. aureus, and E. coli.

Chemische Eigenschaften

Red-Orange Crystalline Powder

Verwenden

Rifaximin is a non-absorbable semisynthetic Rifamycin antibiotic.

Definition

ChEBI: A semisynthetic member of the class of rifamycins and non-systemic gastrointestinal site-specific broad spectrum antibiotic. Used in the treatment of traveller's diarrhoea, hepatic encephalopathy and irritable bowel syndrome.

Antimicrobial activity

The in-vitro activity is slightly inferior to that of rifampicin. The MIC90 for Gram-positive cocci is well below 1 mg/L, with the exception of enterococci (MIC 2–8 mg/L). Among intestinal pathogens C. difficile is sensitive (MIC90 0.8 mg/L), Esch. coli, Salmonella spp. and Shigella spp. are inhibited by 4–8 mg/L. Campylobacter jejuni is mostly insensitive.

Pharmazeutische Anwendungen

A semisynthetic derivative of rifamycin S formulated for oral administration. It is poorly absorbed from the gastrointestinal tract, where its high concentrations are effective against a variety of gastrointestinal pathogens.

Mechanism of action

The mechanism of action of pyrazinamide is unknown, but recent findings suggest that pyrazinamide may be active either totally or in part as a pro-drug. Susceptible organisms produce pyrazinamidase, which is responsible for conversion of pyrazinamide to pyrazinoic acid intracellularly. Mutation in the pyrazinamidase gene (pncA) results in resistant strains of M . tuberculosis. Pyrazinoic acid has been shown to possess biological activity at a pH 5.4 or lower, in contract in vitro tests that show pyrazinoic acid is 8- to 16-fold less active than pyrazinamide . Pyrazinoic acid may lower the pH in the immediate surroundings of the M . tuberculosis to such an extent that the organism is unable to grow, but this physicochemical property appears to account for only some of the activity. The protonated pyrazinoic acid also can permeate the mycobacterial membrane to lower the pH of the cytoplasm. Recent evidence suggests that pyrazinoic acid decreases membrane potential in older, nonreplicating bacilli, thus decreasing membrane transport, and interferes with the energetics of the membrane.

Pharmakokinetik

Oral absorption is very low. However, a fraction of the dose may be absorbed and rapidly eliminated through the bile. A 400 mg oral dose produces a maximum plasma concentration of 3.8 mg/L after 1.2 h. The plasma half-life is 5.8 h. Up to 90% of the administered dose is concentrated in the gut, less than 0.2% in the liver and kidney, and less than 0.01% in other tissues.

Clinical Use

It is used for a variety of gastrointestinal diseases, including the treatment of traveler’s diarrhea. Preliminary results suggest clinical efficacy in the therapy of hepatic encephalopathy and of C. difficile infections.

Nebenwirkungen

Oral doses up to 100 mg/kg for 6 months produced no significant signs of toxicity to rats. Teratogenic effects in rats and rabbits have been reported (pregnancy category C).
Very few adverse effects were reported during human treatment, mostly gastrointestinal discomfort. Prolonged therapy was associated with infrequent urticarial skin reactions.

Stoffwechsel

Pyrazinamide is readily absorbed after oral administration, but little of the intact molecule is excreted unchanged. The major metabolic route consists of hydrolysis by hepatic microsomal pyrazinamidase to pyrazinoic acid, which may then be oxidized by xanthine oxidase to 5-hydroxypyrazinoic acid. The latter compound may appear in the urine either free or as a conjugate with glycine.

Rifaximin Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Rifaximin Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 485)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hebei Mojin Biotechnology Co., Ltd
+8613288715578
sales@hbmojin.com China 12468 58
Wuhan Fortuna Chemical Co., Ltd
+86-027-59207850
info@fortunachem.com China 6001 58
Zibo Hangyu Biotechnology Development Co., Ltd
+86-0533-2185556 +8617865335152
Mandy@hangyubiotech.com China 11013 58
Sigma Audley
+86-18336680971 +86-18126314766
nova@sh-teruiop.com China 525 58
Henan Suikang Pharmaceutical Co.,Ltd.
+86-18239973690 +86-18239973690
sales@suikangpharm.com China 186 58
Capot Chemical Co.,Ltd.
571-85586718 +8613336195806
sales@capotchem.com China 29797 60
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512
info@tianfuchem.com China 21689 55
Hubei XinRunde Chemical Co., Ltd.
+8615102730682
bruce@xrdchem.cn CHINA 566 55
career henan chemical co
+86-0371-86658258
sales@coreychem.com China 29914 58
Hubei Jusheng Technology Co.,Ltd.
18871490254
linda@hubeijusheng.com CHINA 28180 58

80621-81-4()Verwandte Suche:


  • 2s-acetyloxy-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11, 16,20,22,24,26-octamethyl-2,7-(epoxypentoeleca(1,11,13)trienimino)benzofuro[4,5-e]pyride[1,2-a]benzimidazole-1,15(2h)-dione
  • normix
  • ole-1,15(2h)-dione,25-(acetyloxy)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16
  • rifamycinl105
  • rifamycinl105sv
  • rifaxidin
  • RIFAXIMIN
  • RIFACOL
  • 4-DEOXY-4'-METHYLPYRIDO[1',2'-1,2]IMIDAZO[5,4-C]RIFAMYCIN SV
  • 4-Deoxy-4methylpyridol[121,2]imidazo[5,4-c]rifamycin SV
  • 2,7-(Epoxypentadeca1,11,13trienimino)benzofuro4,5-epyrido1,2-abenzimidazole-1,15(2H)-dione, 25-(acetyloxy)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-, (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-
  • ,20,22,24,26-octamethyl-,(2s-(2r*,16z,18e,20r*,21r*,22s*,23s*,24s*,25r*,26s*,
  • 2,7-(epoxypentadeca(1,11,13)trienimino)benzofuro(4,5-e)pyrido(1,2-a)benzimidaz
  • 28e))-27r
  • fatroximin
  • l105
  • l105(ansamacrolideantibiotic)
  • l105sv
  • Rifacol, 4-Deoxy-4μ-methylpyrido[1μ,2μ-1,2]imidazo[5,4-c]rifamycin SV
  • (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26S,27S,28E)-5,6,21,23,25 Pentahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-2,7-(epoxypentadeca(1,11,13)trienimino)benzofuro(4,5-e)pyrido(1,2-a)benzimidazole-1,15(2H)-dione, 25-acetate
  • 2,7-(Epoxypentadeca(1,11,13)trienimino)benzofuro(4,5-e)pyrido(1,2-a)benzimidazole-1,15(2H)- dione, 25-(acetyloxy)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-, (2S-(2R*,16Z,18E,20R*,21R*,22S*,23S*,24S*,25R*,26S*,27R*,28E))
  • CILIFRUITEXTRACT
  • RifaxiMin(Xifaxan)
  • Earthworm Extract
  • (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-25-(acetyloxy)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-2,7-(Epoxypentadeca[1,11,13]trienimino)benzofuro[4,5-e]pyrido[1,2-a]benzimidazole-1-15(2H)-dione
  • The earthworm extract
  • Rifaximin(Rifacol)
  • Earthworm extract / Earthworm Protein
  • Rifaximin for system suitability CRS
  • Rifaximin >
  • Rifaximin CRS
  • Rifaximin Standard
  • Ground dragon extract
  • Rifaximin USP/EP/BP
  • Rifaximin (10mM in DMSO)
  • Rifaximin (Y0001074)
  • Rifaximin D6Q: What is Rifaximin D6 Q: What is the CAS Number of Rifaximin D6 Q: What is the storage condition of Rifaximin D6 Q: What are the applications of Rifaximin D6
  • Rifaximin System suitability(Y0001075)
  • RifaximinQ: What is Rifaximin Q: What is the CAS Number of Rifaximin Q: What is the storage condition of Rifaximin Q: What are the applications of Rifaximin
  • Rifaximin (RFX) extrapure, 98%
  • Riimim
  • Rifaximinn
  • (English name): Rifaximin
  • Extract of dragon's Dragon
  • XIFAXAN
  • RIFAMIXIN
  • Refaximin
  • Pork medicinal herbs
  • BRN 3584528
  • Rifaxin
  • Ritacol
  • 80621-81-4
  • C43H51N3O11
  • XIFAXAN
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
  • API
  • Antibiotics
Copyright 2019 © ChemicalBook. All rights reserved